Webinar: Addressing the challenges in enrolling oncology and rare disease trial participants

Focused on:

Date: 15th December

Days old: 4801

Time: London 3PM / New York 10AM

Watch Now for FREE

Learn more about Business Review Webinars

Already Registered?

If you have previously registered for this event, please login below:

Register

All fields below are required.

First Name

Last Name

Telephone

Company

Job Title

City

Country

I accept that the data provided on this form will be processed, stored and used in accordance with the terms set out in our Privacy policy and T&C’s.

Innovative CTL program for faster, more efficient enrollment

Successful accrual to oncology and other rare disease clinical trials present diverse and unique challenges for study teams. We have found that to be successful, accrual strategies must shift the focus from prospective patients to the team providing healthcare, and concentrate on providing information and critical support to the treatment team, lowering historic barriers to enrollment. In oncology, the treatment team serves as either enabler or gatekeeper when clinical trials are offered as a treatment option.

The innovative Clinical Trial Liaison (CTL) program offers support to the treatment team, and enables them to be better prepared for patient inquiries.

Acurian provides insight into the new paradigm of enrolling oncology and rare disease studies.

Presented by

Edwin Watson,

Senior Director of Oncology

Ed Watson is responsible for Acurian's Oncology Programs, and previously at Acurian was in charge of Corporate Development, responsible for many external business relationships and supporting the continued enhancement and development of Acurian's capabilities in patient accrual in clinical trials. Watson brings 16 years experience with the pharmaceutical industry at Schering-Plough, Pharmacia and GlaxoSmithKline, where he held senior positions in marketing, pharmaceutical pricing strategy and the technical operations supporting those efforts.

Download Slides

Please login to download the slides

Key Learning Objectives

Investigating why oncology and rare diseases are different from other therapeutic areas
Exploring challenges of enrolling and distinguishing them from other therapeutic areas
Providing information and critical support to the healthcare team to lower barriers to enrollment
Understanding what implications to approach for improving or changing process of clinical trials

Audience

CEO/President/Chairman/Executive Director
Clinical Operations
Clinical Trial/Operations - VP/Director/Manager
Trial Site Management
CEO
VP
and Director level personnel in oncology focusing on clinical trials
clinical outsourcing
clinical operations.